Preliminary study of glycopyrrolate in the management of drooling

Journal of Paediatrics and Child Health

Volumn 33, Issue 1, 1997, Pages 52-54

  Stern, L M ^a,b  

^a Crippled Children's Assoc S A   (Australia)

^b Crippled Children's Assoc SA Inc   (Australia)

Author keywords

disabled children; drooling; glycopyrrolate

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM BROMIDE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; HYPERSALIVATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0031055512     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1997.tb00991.x     Document Type: Article

References (20)

1. Blasco PA, Allaire JH, and participants of the Consortium on Drooling. Drooling in the developmentally disabled: Management practices and recommendations. Dev. Med. Child Neurol. 1992; 34: 849-62.
2. Samelstad KM. Treatment techniques to encourage lip closure and decrease drooling in persons with cerebral palsy. Occup. Ther. J. Res. 1988; 8: 164-75.
3. McCracken A. Drool control and tongue thrust therapy for the mentally retarded. Am. J. Occup. Ther. 1978; 32: 79-85.
4. Ray SA, Bundy AC, Nelson DL. Decreasing drooling through techniques to facilitate mouth closure. Am. J. Occup. Ther. 1983; 37: 749-53.
5. Camp-Bruno JA, Winsberg BG, Green-Parsons AR et al. Efficacy of benztropine therapy for drooling. Dev. Med. Child Neurol. 1989; 31: 309-19.
6. Owen SE, Stern LM. Management of drooling in cerebral palsy: three single case studies. Int. J. Rehabil. Res. 1992; 15: 166-9.
7. Reddihough D, Johnson H, Staples M et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev. Med. Child Neurol. 1990; 32: 985-9.
8. Lewis DW, Fontana C, Mehallick LK et al. Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev. Med. Chid Neurol. 1994; 36: 484-6.
9. Burton MJ. The surgical management of drooling. Dev. Med. Child Neurol. 1991; 33: 1110-16.
10. Webb K, Reddihough DS, Johnson H et al. Long-term outcome of saliva-control surgery. Dev. Med. Child Neurol. 1995; 37: 755-62.
11. Bailey CM, Wadsworth PV. Treatment of the drooling child by submandibular duct transposition. J. Laryngol. Otol. 1985; 99: 1111-7.
12. Guerin RL. Surgical management of drooling. Arch. Otolaryngol. 1979; 105: 535-7.
13. Crysdale WS, White A. Submandibular duct relocation for drooling: a 10-year experience with 194 patients. Otolaryngol. Head Neck Surg. 1989; 101: 87-92.
14. Mirakhur RK, Dundee JW, Jones CJ. Evaluation of the anticholinergic actions of glycopyrronium bromide. Br. J. Clin. Pharmacol. 1978; 5: 77-84.
15. Mirakhur RK, Dundee JW. Comparison of the effects of atropine and glycopyrrolate on various end-organs. J. R. Soc. Med. 1980; 73: 727-30.
16. Bachrach S, Walter R, Trzcinski K. The use of glycopyrrolate for drooling in children with cerebral palsy. Dev. Med. Child Neurol. 1995; (Suppl. 13) 37: 10.
17. Blasco PA, Stansbury JCK. Glycopyrrolate treatment of chronic drooling. Arch. Pediatr. Adolesc. Med. 1996; 150: 932-5.
18. Innes IR, Nickerson M. Atropine scopolamine and related antimuscarinic drugs. In: Goodman LS, Gilman A eds. The Pharmacological Basis of Therapeutics, 5th edn. MacMillan, New York, 1975; 514-32.
19. Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988; 3: 73-8.
20. Good WV, Crain LS. Esotropia associated with use of the scopolamine patch. Pediatrics 1996; 97: 126-7.